Although these anti-tumoral effects highlight PPAR-γ activation as a potential therapeutic option for diverse cancers, a consistent protumorigenic role for PPAR-γ has been suggested in bladder cancer [83,84,85], indicating a tissue-specific role for this transcription factor. Here, PPARG is linked to cancer.